Adhera Therapeutics, Inc. Derivative Liability, Current
Adhera Therapeutics, Inc. had Derivative Liability, Current of $6.89 million as of 2023-09-30, per its 10-Q filed 2023-11-20.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:DerivativeLiabilitiesCurrent · last filed 2023-11-20
- 2023-09-30: Derivative Liability, Current $6.89M.
- 2023-06-30: Derivative Liability, Current $4.25M.
- 2023-03-31: Derivative Liability, Current $5.89M.
- 2022-12-31: Derivative Liability, Current $6.39M; Derivative Liability, Current as first filed $6.39M.
| Period end | Derivative Liability, Current | Derivative Liability, Current as first filed |
|---|---|---|
| 2023-09-30 | $6.89M 10-Q · filed 2023-11-20 | |
| 2023-06-30 | $4.25M 10-Q · filed 2023-08-21 | |
| 2023-03-31 | $5.89M 10-Q · filed 2023-05-22 | |
| 2022-12-31 | $6.39M 10-Q · filed 2023-11-20 | $6.39M 10-K · filed 2023-03-31 |
| 2022-09-30 | $7.26M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $7.10M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $7.17M 10-Q · filed 2022-05-16 | |
| 2021-12-31 | $7.70M 10-K · filed 2023-03-31 | |
| 2021-09-30 | $3.48M 10-Q · filed 2021-11-22 | |
| 2021-06-30 | $103.00K 10-Q · filed 2021-08-23 | |
| 2017-09-30 | $115.27K 10-Q · filed 2017-11-13 | |
| 2017-06-30 | $195.94K 10-Q · filed 2017-08-14 |